Back to Explore

www.kletthamerinsights.com

Kletthamer Insights is an independent non-sponsored analytical research on Pharma open innovation, business development, M&As, CVC, and strategic investment activities.

On the social web

Subscribe via Mastodon, Threads, Flipboard, or any social web platform.

Latest Posts

The cost of chasing validated science: how Pfizer overpays when it needs certainty

Adil Mirza · 15 Jul 2026

The $85 Billion shopping spree: How AbbVie bought, borrowed and built its way out of a Humira cliff

Adil Mirza · 10 Jul 2026

Will AstraZeneca's open innovation engine turn it into the next most valuable pharma company?

Adil Mirza · 7 Jul 2026

Contributors

Adil Mirza

Creator of www.kletthamerinsights.com